课题基金 / 基金详情

Gene-Environment Interactions in Glaucoma

Gene-Environment Interactions in Glaucoma
青光眼的基因与环境相互作用
批准号:
8450865
负责人:
Louis Robert Pasquale
金额:
$45.42万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2014-03-31

项目摘要

项目成果

Louis Robert Pasquale的其他基金

相似基金

相关文献

中文摘要
翻译
原发性开角型青光眼(Primary open-angle glaucoma,POAG)是一种眼内压依赖性、缓慢进展的青光眼, 最终导致失明的神经病变。基于人口的调查数据表明, 功能障碍,如通过眼部血液动力学测试、眼部灌注压测量和 血管内皮功能障碍的标志物,在青光眼中很重要。此外,女性生殖 根据绝经年龄和绝经后激素使用情况评估的属性也可能在以下方面发挥作用: POAG。在这次重新提交的报告中,我们建议进一步探讨以前资助的工作中的重要发现, 通过研究血管功能障碍和雌激素水平的关键基因环境相互作用, POAG。对于血管功能障碍的研究,我们打算使用预先存在的高密度全基因组, 来自5项研究的基因分型数据(护士健康研究[NHS],健康专业人员随访研究[HPFS], 大众眼耳医院、妇女健康研究[WHS]和NEIGHBOR联盟)来选择一个小组 的标记基因,特别是参与介导血管张力,并确定顶部的单核苷酸 与POAG相关的SNP。第二,我们会延长国民保健服务及自置居所资助计划的跟进时间 参与者到2014年,并研究内皮功能障碍的生物标志物(ICAM-1,E-选择素)之间的关系, 和TNF α)和POAG事件,使用巢式病例对照组。最后,我们将评估 POAG患者中调节血管张力的主要SNP与内皮功能障碍的生物标志物相互作用 对照组来自NHS和HPFS。由于雌激素影响血管张力,我们也将评估相互作用 在介导血管张力和女性生殖属性的最高SNP之间(见下文), 在NHS和WHS中的女性。为了进一步探索性别生物学,我们提出了一项前瞻性队列研究, 评估女性生殖属性(初潮年龄、产次和口服避孕药)之间的关系 使用)和NHS参与者中的POAG风险。然后,我们将评估基因在雌激素中的作用- 代谢途径,通过使用来自5个基因组的现有高密度全基因组基因分型数据, 问题研究最后,由于影响雌激素水平的基因-环境相互作用可能与原发性开角型青光眼有关, 计划确定是否顶级雌激素代谢SNP与女性的各种属性相互作用, 国家卫生服务体系和妇女卫生服务体系中妇女的生殖健康。基因和生物学的结合 将性别生物学和血管功能障碍与POAG联系起来的环境因素可能导致更多的 合理治疗疾病。此外,这项研究可能会导致基因型特定的生活方式 预防POAG的修饰策略。
英文摘要
Primary open-angle glaucoma (POAG) is an intraocular pressure (IOP)-dependent, slowly progressive optic neuropathy that ultimately leads to blindness. Data from population-based surveys demonstrate that vascular dysfunction, as assessed with ocular hemodynamic testing, measurements of ocular perfusion pressure and markers of vascular endothelial dysfunction, is important in glaucoma. Furthermore, female reproductive attributes, as assessed by age at menopause and postmenopausal hormone use, may also play a role in POAG. In this resubmission, we propose to further explore important findings from the previously funded work, by examining key gene environment interactions of vascular dysfunction and estrogen levels in relation to POAG. For the study of vascular dysfunction, we intend to use pre-existing high density whole genome-wide genotyping data from 5 studies (Nurses Health Study [NHS], Health Professionals Follow-up Study [HPFS], Mass Eye and Ear Infirmary, Women's Health Study [WHS] and the NEIGHBOR consortium) to select a panel of markers in genes specifially involved in mediating vascular tone, and identify the top single nucleotide polymorphisms (SNPs) associated with POAG. Second, we will extend the follow-up of NHS and HPFS participants to 2014, and study the relation between biomarkers of endothelial dysfunction (ICAM-1, E-selectin and TNF alpha) and incident POAG, using a nested case control group. Finally, we will assess whether the top SNPs mediating vascular tone interact with biomarkers of endothelial dysfunction in POAG using a case control group from NHS and HPFS. Since estrogen influences vascular tone, we will also assess interactions between the top SNPs mediating vasuclar tone and attributes of female reproduction (see below), among women in the NHS and WHS. To further explore gender biology we propose a prospective cohort study to assess the relationship between female reproductive attributes (age at menarche, parity and oral contraceptive use) and POAG risk among NHS participants. Then, we will evaluate the role of genes in the estrogen- metabolizing pathway, by using the pre-existing high density whole genome-wide genotyping data from the 5 studies. Finally, as gene-environment interactions that influence estrogen levels may be involved in POAG, we plan to ascertain whether the top estrogen metabolizing SNPs interact with various attributes of female reproductive health among women in the NHS and WHS. The discovery of the combination of genetic and environment factors that serve to link gender biology and vascular dysfunction to POAG could lead to more rationale treatments for the disease. Furthermore, this research could lead to genotype-specific lifestyle modification strategies to prevent POAG.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding the clinical impact of cumulative genetic risk to glaucoma
Understanding the clinical impact of cumulative genetic risk to glaucoma
Understanding the clinical impact of cumulative genetic risk to glaucoma
Genes and Environment Initiative in Glaucoma
海外基金